Comparison of the EF-1α and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus

Anticancer Research

Volumn 22, Issue 6 A, 2002, Pages 3325-3330

  Teschendorf, Christian ^a,b   Warrington Jr , Kenneth H ^a   Siemann, Dietmar W ^a   Muzyczka, Nicholas ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

CMV promoter; EF 1 promoter; Recombinant AAV; Stable cell lines

Indexed keywords

ELONGATION FACTOR 1ALPHA; GREEN FLUORESCENT PROTEIN;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENGINEERING; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE CASSETTE; GENE SILENCING; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ANIMALS; CYTOMEGALOVIRUS; DEPENDOVIRUS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HT29 CELLS; HUMANS; LUMINESCENT PROTEINS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PEPTIDE ELONGATION FACTOR 1; PROMOTER REGIONS (GENETICS); TRANSFECTION; TRANSGENES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0036871275     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Foecking MK and Hofstetter H: Powerful and versatile enhancer-promoter unit for mammalian Y expression vectors. Gene 45: 101-5, 1986.
2. Kim DW, Harada T, Saito I and Miyamura T: An efficient expression vector for stable expression in human liver cells. Gene 134: 307-8, 1993.
3. Xiao W, Berta SC, Lu MM, Moscioni AD, Tazelaar J and Wilson JM: Adeno-associated virus as a vector for liver-directed gene therapy. J Virol 72: 10222-6, 1998.
4. Najjar SM and Lewis RE: Persistent expression of foreign genes in cultured hepatocytes: expression vectors. Gene 230: 41-5, 1999.
5. Forni G and Boggio K: Cytokine gene-engineered vaccines. Curr Opin Mol Ther 1: 34-8, 1999.
6. Furth PA, St Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H and Henninghausen L: Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci 91: 9302-9306, 1994.
7. Ambs, S, Dennis S, Fairman J, Wright M and Papkoff J: Inhibition of tumor growth correlates with the expression level of a human angiostatin transgene in transfected B 16F 10 Melanoma cells. Cancer Res 59: 5773-5777, 1999.
8. Yoon SS, Eto H, Lin C, Nakamura H, Pawlik TM, Song SU and Tanabe KK: Mouse endostatin inhibits the formation of lung and liver metastasis. Cancer Res 59: 6251-6256, 1999.
9. Carter PJ and Samulski RJ: Adeno-associated viral vectors as gene delivery vehicles. Int J Mol Med 6: 17-27, 2000.
10. Grimm D, Kern A, Rittner K and Kleinschmidt JA: Novel tools for production and purification of recombinant adeno-associated virus vectors. Hum Gene Ther 9: 2745-60, 1998.
11. Zolotukhin S, Byrne B, Mason E, Zolotukhin 1, Potter M, Chesnut K, Summerford C, Samulski R and Muzyczka N: Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 6: 973-985, 1999.
12. Gorman CM, Gies D, McCray G and Huang M: The human cytome-galovirus major immediate early promoter can be trans-activated by adenovirus early proteins. Virology 171: 377-85, 1989.
13. Kim DW, Uetsuki T, Kaziro Y, Yamaguchi N and Sugano S: Use of the human elongation factor 1α promoter as a versatile and efficient expression, system. Gene 91: 217-223, 1990.
14. Gopalkrishnan RV, Christiansen KA, Goldstein NI, DePinho RA and Fisher PB: Use of the human EF-1α promoter for expression can significantly increase success in establishing stable cell lines with consistent expression: a study using the tetracycline-inducible system in human cancer cells. Nucl Acid Res 27: 4775-4782, 1999.
15. Snyder RO: Adeno-associated virus-mediated gene delivery. J Gene Med 1: 166-175, 1999.